2410 — TYK Medicines Share News
0.000.00%
Last trade - 00:00- HK$1.24bn
- HK$1.17bn
Brief: Tyk Medicines Says Chairman Purchases Co's Shares On Open Market
Brief: TYK Medicines Says Asandeutertinib Mesylate Tablets (TY-9591) Obtains Conditional Marketing Approval From NMPA
Brief: TYK Medicines Files Legal Proceedings Against Sichuan Huiyu Pharmaceutical Over TY-9591 Agreements
Brief: Tyk Medicines Enters License And Collaboration Agreement With Qilu For Ty-9591 In China
Brief: Tyk Medicines FY Loss Attributable Rmb299.8 Million
Brief: TYK Medicines, Others Agree To Increase Registered Capital Of TYK Bio By RMB6.49 MLN
Brief: TYK Medicines Inc Announces Inclusion Of Asandeutertinib In List Of Products For Priority Review By Center For Drug Evaluation Of NMPA China
Brief: TYK Medicines Granted Drug Manufacturing License By Drug Administration Of Zhejiang Province
Brief: TYK Medicines' Asandeutertinib (TY-9591) To Be Included In List Of Products For Priority Review
Brief: TYK Medicines In Talks For Master Distribution With Sichuan Huichenxin
Brief: TYK Medicines Announces Placing Of 9.2 Mln H Sharers
Brief: TYK Medicines Says Jiang Mingyu Would Be Re-Designated To Non-Executive Director
China Literature drops on removal from Hang Seng Tech Index; Midea, ZTO up
Brief: TYK Medicines To Invest RMB18.0 Million In Limited Partnership Fund
Brief: Tyk Medicines Posts FY Loss Attributable Rmb387 Million